Elevated C-Reactive Protein: Clinical Interpretation and Management

Introduction to C-Reactive Protein

C-Reactive Protein (CRP) is an acute-phase protein produced by the liver in response to inflammatory cytokines, particularly IL-6 and TNF-α, with normal concentrations typically below 3 mg/L in healthy individuals 1, 2
CRP levels can be influenced by demographic factors such as age, sex, race, and socioeconomic status, as well as lifestyle factors including smoking, obesity, and lack of exercise 1, 2, 5, 6

The American Heart Association suggests that high-sensitivity CRP (hsCRP) is an independent marker of cardiovascular risk, and may be used at the physician's discretion in patients at intermediate risk for cardiovascular disease 7
CRP levels may be categorized as follows: <3 mg/L (normal), 3-10 mg/L (low-grade chronic inflammation), and >10 mg/L (indicative of acute inflammation or infection), though the traditional cutoff of 10 mg/L may be outdated 1, 2, 5, 7
Elevated CRP predicts all-cause and cardiovascular mortality in dialysis patients, and is a stronger predictor of cardiovascular events than LDL-cholesterol levels 3, 4

The American College of Cardiology recommends that treatment should target the underlying cause rather than the CRP level itself, and that serial testing of CRP should not be used to monitor the effects of treatment 1, 2, 7
Patients with persistently unexplained marked elevation of CRP (>10 mg/L) after repeated testing should be evaluated for non-cardiovascular causes, and application of secondary prevention measures should not depend on CRP determination 7
CRP measurement in patients with stable coronary disease or acute coronary syndromes may be useful as an independent marker of prognosis for recurrent events 7